Logo image
CRISPR-mediated Ophthalmic Genome Surgery
Journal article

CRISPR-mediated Ophthalmic Genome Surgery

Galaxy Y Cho, Yazeed Abdulla, Jesse D Sengillo, Sally Justus, Kellie A Schaefer, Alexander G Bassuk, Stephen H Tsang and Vinit B Mahajan
Current ophthalmology reports, Vol.5(3), pp.199-206
09/2017
DOI: 10.1007/s40135-017-0144-1
PMCID: PMC5613978
PMID: 28966884
url
https://www.ncbi.nlm.nih.gov/pmc/articles/5613978View
Open Access

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR) is a genome engineering system with great potential for clinical applications due to its versatility and programmability. This review highlights the development and use of CRISPR-mediated ophthalmic genome surgery in recent years.\nDiverse CRISPR techniques are in development to target a wide array of ophthalmic conditions, including inherited and acquired conditions. Preclinical disease modeling and recent successes in gene editing suggest potential efficacy of CRISPR as a therapeutic for inherited conditions. In particular, the treatment of Leber congenital amaurosis with CRISPR-mediated genome surgery is expected to reach clinical trials in the near future.\nTreatment options for inherited retinal dystrophies are currently limited. CRISPR-mediated genome surgery methods may be able to address this unmet need in the future.
CRISPR-Cas induced pluripotent stem cells genome surgery inherited retinal dystrophy

Details

Logo image